How GHK-Cu works
A copper-binding skin peptide with small topical studies and untested systemic injections.
Also called: Copper tripeptide-1, Glycyl-L-histidyl-L-lysine copper, Copper-GHK.
Healing and repair peptides · Copper-binding tripeptide complex.
The peptide holds copper, a mineral used in repair enzymes. In cells and animals, GHK-Cu changes collagen turnover, inflammation and blood-vessel growth. These effects do not show that injections repair tissue in people.
- Copper binding: Changes how copper is carried and released; the formulation affects which chemical forms reach tissue.
- Collagen and matrix turnover: Changes collagen production and the balance of enzymes that rebuild tissue in laboratory studies.
- VEGF and bFGF growth signals: Increases blood-vessel and cell-growth signals in cultured fibroblasts; clinical effects are uncertain.
Half-life: Human systemic half-life is unknown. Minute-scale estimates are not verified human GHK-Cu pharmacokinetics.
Related to GHK-Cu
- BPC-157: An experimental repair peptide with mostly animal evidence and a few small human reports.
- TB-500: A short piece of thymosin beta-4 with no proven repair benefit in humans.
- AHK-Cu: A copper peptide used in scalp serums, with laboratory findings and weak patent-only human data.
- Thymosin beta-4: A peptide studied for eye conditions and skin wounds; tendon-repair injections lack controlled human evidence.
- ARA-290: Experimental peptide studied for small-fiber nerve damage, with uncertain pain relief and safety.
- Ac-SDKP: An experimental repair peptide with old human studies, but no proven healing dose.
Sources
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2026
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA · FDA · 2026
- Concerns regarding the public health risks associated with unapproved peptide products, Therapeutic Goods Administration and Chief Medical Officer · Therapeutic Goods Administration · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you, Health Canada · Health Canada · 2026
- WEGOVY- semaglutide injection, solution WEGOVY- semaglutide tablet, DailyMed · DailyMed · 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2025
- Diabetic foot problems: prevention and management, NICE · 2015
- Biotechnology Inspection Guide (11/91), FDA · 1991
- Copper - Health Professional Fact Sheet, NIH Office of Dietary Supplements
- Treatment of Wilson Disease, NIDDK · NIDDK
- Augmented Skin Beneficial Effects of Thermus Thermophilus and Bacillus Subtilis Mixed-Culture Ferment Extract by Tripeptide GHK-Cu., Wang J et al. · Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026
- THE EFFICACY OF 2% COPPER PEPTIDE (GHK-Cu) SERUM FOR EYEBROW HYPOTRICHOSIS: A RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, SPLIT-FACE COMPARATIVE STUDY, Bo SL et al. · Procedia of Multidisciplinary Research · 2026
- The Regenerative Potential of GHK-Cu in Aesthetic Medicine., Mokhtar J et al. · Aesthetic surgery journal · 2026
- A study comparing the effect of dermaroller versus dermaroller with copper peptide in the management of acne scars, 2025
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.